Home
About
Overview
Sharing Data
ORCID
Help
History (0)
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Results (140)
More Search Options
Match
Type
Why
Diagnosis and Treatment of Patients With Acute Myeloid Leukemia With Myelodysplasia-Related Changes (AML-MRC).
Academic Article
Why?
When to obtain genomic data in acute myeloid leukemia (AML) and which mutations matter.
Academic Article
Why?
When to obtain genomic data in acute myeloid leukemia (AML) and which mutations matter.
Academic Article
Why?
FLT3 inhibitor maintenance after allogeneic stem cell transplantation in FLT3-mutated acute myeloid leukemia (AML) patients.
Academic Article
Why?
High dose cytarabine and mitoxantrone: an effective induction regimen for high-risk acute myeloid leukemia (AML).
Academic Article
Why?
The AML1 and ETO genes in acute myeloid leukemia with a t(8;21).
Academic Article
Why?
Identification of novel Runx1 (AML1) translocation partner genes SH3D19, YTHDf2, and ZNF687 in acute myeloid leukemia.
Academic Article
Why?
Detection of DNA rearrangements in the AML1 and ETO loci and of an AML1/ETO fusion mRNA in patients with t(8;21) acute myeloid leukemia.
Academic Article
Why?
The leukemic fusion gene AML1-MDS1-EVI1 suppresses CEBPA in acute myeloid leukemia by activation of Calreticulin.
Academic Article
Why?
Prognostic significance of the AML1-ETO fusion transcript expression in children and young adults with t(8;21) acute myeloid leukemia.
Academic Article
Why?
Cheng, Jason X.
Person
Why?
Identification of pericentric inversion 12, inv(12)(p13.1q11), by fluorescence in situ hybridization in a patient with acute myeloid leukemia (AML-M6).
Academic Article
Why?
Allogeneic hematopoietic cell transplantation compared to chemotherapy consolidation in older acute myeloid leukemia (AML) patients 60-75 years in first complete remission (CR1): an alliance (A151509), SWOG, ECOG-ACRIN, and CIBMTR study.
Academic Article
Why?
Genomic landscape of patients with FLT3-mutated acute myeloid leukemia (AML) treated within the CALGB 10603/RATIFY trial.
Academic Article
Why?
Granulocyte-macrophage colony-stimulating factor (GM-CSF)-secreting cellular immunotherapy in combination with autologous stem cell transplantation (ASCT) as postremission therapy for acute myeloid leukemia (AML).
Academic Article
Why?
Per Page
15
25
50
100
Page
of 10
Next
Prev
Search Criteria
Acute myeloid leukemia
AML
Filter by Type
All
(140)
People
(47)
Research
(93)
_
Click "Why?" to see why an item matched the search.